UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders

Progress in neuro-psychopharmacology & biological psychiatry, 2019-07, Vol.93, p.182-188

2019

Link zum Volltext

Verfügbarkeit prüfen

Discrete-event simulation applied to a radiotherapy process: A case study of a cancer center

Brazilian journal of operations & production management, 2021-01, Vol.18 (1), p.1-20

2021

Link zum Volltext

Verfügbarkeit prüfen

Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders

Reviews in the neurosciences, 2017-10, Vol.28 (7), p.739

2017

Link zum Volltext

Verfügbarkeit prüfen

Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder

Psychiatry and clinical neurosciences, 2017-09, Vol.71 (9), p.624-636

2017

Link zum Volltext

Verfügbarkeit prüfen

Challenges and developments in research of the early stages of bipolar disorder

Revista brasileira de psiquiatria, 2016-10, Vol.38 (4), p.329-337

2016

Link zum Volltext

Verfügbarkeit prüfen

Hippocampus size does not correlate with body mass index in bipolar disorder

Revista brasileira de psiquiatria, 2016-03, Vol.38 (1), p.86

2016

Link zum Volltext

Verfügbarkeit prüfen

1H-NMR, 1H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profiling

International Journal of Bipolar Disorders, 2017-06, Vol.5 (1), p.23-23, Article 23

2017

Link zum Volltext

Verfügbarkeit prüfen

Functioning in early and late stages of schizophrenia

Trends in psychiatry and psychotherapy, 2014-12, Vol.36 (4), p.209-213

2014

Link zum Volltext

Verfügbarkeit prüfen

rTMS as an add-on treatment for resistant obsessive-compulsive symptoms in patients with schizophrenia: report of three cases

Revista brasileira de psiquiatria, 2013-04, Vol.35 (2), p.210

2013

Link zum Volltext

Verfügbarkeit prüfen

3.3 DISTURBANCES IN NEURAL OSCILLATIONS, GLUTAMATE, AND GABA: EFFECTS OF KETAMINE AND COMPARISON TO SCHIZOPHRENIA

Schizophrenia bulletin, 2018-04, Vol.44 (suppl_1), p.S2-S2

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum concentrations of brain-derived neurotrophic factor in patients diagnosed with gender dysphoria undergoing sex reassignment surgery

Trends in psychiatry and psychotherapy, 2017-01, Vol.39 (1), p.43-47

2017

Link zum Volltext

Verfügbarkeit prüfen

Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder

Journal of psychiatric research, 2019-12, Vol.119, p.67-75

2019

Link zum Volltext

Verfügbarkeit prüfen

A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics

Psychiatry research, 2017-12, Vol.258, p.268-273

2017

Link zum Volltext

Verfügbarkeit prüfen

Adipokines, metabolic dysfunction and illness course in bipolar disorder

Journal of psychiatric research, 2016-03, Vol.74, p.63-69

2016

Link zum Volltext

Verfügbarkeit prüfen

Impaired glucose metabolism moderates the course of illness in bipolar disorder

Journal of affective disorders, 2016-05, Vol.195, p.57-62

2016

Link zum Volltext

Verfügbarkeit prüfen

Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity

Journal of psychiatric research, 2012-06, Vol.46 (6), p.819-824

2012

Link zum Volltext

Verfügbarkeit prüfen

Accessing Gene Expression in Treatment-Resistant Schizophrenia

Molecular neurobiology, 2018-08, Vol.55 (8), p.7000-7008

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: A study in adolescent rats with ketamine-induced model of schizophrenia

Schizophrenia research, 2012-11, Vol.141 (2), p.162-167

2012

Link zum Volltext

Verfügbarkeit prüfen

Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine

The journal of clinical psychiatry, 2009-10, Vol.70 (10), p.1416

2009

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Oxidative and nitrosative stress biomarkers in chronic schizophrenia”

Psychiatry research, 2019-03, Vol.273, p.809-809

2019

Link zum Volltext

Verfügbarkeit prüfen

An immunological age index in bipolar disorder: A confirmatory factor analysis of putative immunosenescence markers and associations with clinical characteristics

International journal of methods in psychiatric research, 2018-12, Vol.27 (4), p.e1614-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Insights into the Effects of Crack Abuse on the Human Metabolome Using a NMR Approach

Journal of proteome research, 2019-01, Vol.18 (1), p.341-348, Article acs.jproteome.8b00646

2019

Link zum Volltext

Verfügbarkeit prüfen

Brain-derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course

Bipolar disorders, 2016-06, Vol.18 (4), p.373-378

2016

Link zum Volltext

Verfügbarkeit prüfen

Bipolar disorder course, impaired glucose metabolism and antioxidant enzymes activities: A preliminary report

Journal of psychiatric research, 2016-09, Vol.80, p.38-44

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation

Neuroscience letters, 2011-03, Vol.491 (3), p.207-210

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(60)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Psychiatry
(31)
Humans
(29)
Male
(25)
Female
(24)
Adult
(22)
Middle Aged
(15)
Bipolar Disorder
(14)
Schizophrenia
(13)
Neurosciences & Neurology
(11)
Neurosciences
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Psychology. Psychoanalysis. Psychiatry
(8)
Psychopathology. Psychiatry
(8)
Bipolar Disorder - Blood
(7)
Brain-Derived Neurotrophic Factor - Blood
(7)
Adult And Adolescent Clinical Studies
(6)
Animals
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders

Discrete-event simulation applied to a radiotherapy process: A case study of a cancer center

Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders

Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder

Challenges and developments in research of the early stages of bipolar disorder

Hippocampus size does not correlate with body mass index in bipolar disorder

1H-NMR, 1H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profiling

Functioning in early and late stages of schizophrenia

rTMS as an add-on treatment for resistant obsessive-compulsive symptoms in patients with schizophrenia: report of three cases

3.3 DISTURBANCES IN NEURAL OSCILLATIONS, GLUTAMATE, AND GABA: EFFECTS OF KETAMINE AND COMPARISON TO SCHIZOPHRENIA

Serum concentrations of brain-derived neurotrophic factor in patients diagnosed with gender dysphoria undergoing sex reassignment surgery

Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder

A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics

Adipokines, metabolic dysfunction and illness course in bipolar disorder

Impaired glucose metabolism moderates the course of illness in bipolar disorder

Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity

Accessing Gene Expression in Treatment-Resistant Schizophrenia

Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: A study in adolescent rats with ketamine-induced model of schizophrenia

Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine

Corrigendum to “Oxidative and nitrosative stress biomarkers in chronic schizophrenia”

An immunological age index in bipolar disorder: A confirmatory factor analysis of putative immunosenescence markers and associations with clinical characteristics

Insights into the Effects of Crack Abuse on the Human Metabolome Using a NMR Approach

Brain-derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course

Bipolar disorder course, impaired glucose metabolism and antioxidant enzymes activities: A preliminary report

Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation

Suchergebnisse filtern